Contact Us

Service Line:+1-315-239-3085

Address:FL-4, Building A5, International Enterprise Community, Tianjin, China

Email:info@kmdbioscience.com

Online Inquery

  •   
  •   
  •   
  • Refresh

Anti-Human CD19 & CD3E Recombinant Antibody(Duvortuxizumab)

Product Information
Catalog Number YR1422
Product Name Anti-Human CD19 & CD3E Recombinant Antibody(Duvortuxizumab)
Molecular Name Duvortuxizumab
Alias Anti-CD19 & CD3E Recombinant Antibody, Research Grade Duvortuxizumab
CAS Number 1831098-91-9
Target CD19 & CD3E[Homo sapiens]
Isotype scFv -h-CH2-CH3(_scFv)_h-CH2-CH3
Clonity Monoclonal
Source CHO Cells
Size 1mg, 5mg
Concentration 1mg/ml
Purity >95% as determined by SDS-PAGE
Buffer PBS, pH7.5
Background Duvortuxizumab (INN) is a chimeric/humanized monoclonal antibody designed for the treatment of B-cell malignancies. This drug was developed by Janssen Global Services.
Storage It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Note This product is for research use only.